Here are Tuesday's biggest analyst calls: SpaceX, Apple, Broadcom, CoreWeave, Palantir, Intel & more

Wall Street analysts issued a broad set of mostly positive recommendations, including upgrades of Broadcom, MercadoLibre, Ferguson and MACOM, and new Buy or Outperform initiations across several sectors. Price-target increases included Apple to $390 from $360 and Palantir to $260 from $225; Bernstein raised CoreWeave’s target to $54 from $51 while maintaining Underperform. The calls cite potential growth and valuation appeal, but also note risks including component inflation and supply constraints at Apple and funding and AI-trade sentiment concerns at CoreWeave.

Analysis

This is a low-information bundle of broker opinions, not a common fundamental catalyst; near-term moves are more likely positioning and headline-driven than durable estimate revisions. The most consequential tension is AI funding: the bullish Broadcom thesis appears to rely partly on future AI-company IPO proceeds supporting spending, while CoreWeave is explicitly being discounted for funding exposure. That is a financing-cycle trade, not simply an AI-demand trade. An IPO does not establish that proceeds become incremental, binding Broadcom orders; verify customer commitments, concentration, and cash conversion before underwriting the claim.

Over 1–3 months, MTSI and INTC have identifiable earnings catalysts, but the calls themselves offer little edge without results versus expectations. For Apple, pricing can cushion component inflation only if volumes and mix hold; price increases that impair demand would turn a margin defense into a revenue risk. Over 6–18 months, Trimble’s upside depends on transformation milestones translating into recurring revenue and cash generation, not the cited valuation alone. Construction materials weakness at Knife River could be cyclical rather than company-specific; recovery in project activity and pricing would challenge the bearish relative signal.

Contrarian view: the breadth of bullish initiations/upgrades may encourage indiscriminate dip-buying, yet most cited targets and ratings are not independently verified evidence of improving fundamentals. Prefer selective, catalyst-led exposure over a basket. Falsifiers for the AI relative-value thesis include cancellation or deferral of customer spending, worsening funding terms, or evidence that Broadcom’s AI orders are not diversified.

Key Decisions for Investors

• Consider a small, defined-risk relative-value position: long AVGO / short CRWV, sized to limit AI-factor exposure. The thesis is comparatively lower sensitivity to standalone funding stress, not immunity to a reversal in AI capex. Enter only after checking Broadcom customer/order disclosures and CoreWeave financing terms; cut if Broadcom order visibility weakens or CRWV funding risk materially improves without a corresponding change in valuation.
• Keep MTSI and INTC on an event watchlist rather than chasing broker calls into results. Add only if reported orders/guidance and forward demand support the thesis; invalidate on guidance cuts, weaker backlog or adverse margin commentary.
• Treat TRMB as a 1–3 month execution watch, not an automatic value buy. Seek evidence of recurring-revenue progress, operating leverage and cash conversion; step aside if transformation milestones slip or growth decelerates.
• For AAPL, monitor unit volumes and gross-margin guidance alongside realized pricing. A volume/mix deterioration or continued component-cost pressure that overwhelms pricing would falsify the near-term margin-cushion thesis; no standalone trade from this note alone.